CRISPR Therapeutics appoints Julianne Bruno as COO effective May 23, 2024

CRISPR Therapeutics AG

Bruno previously SVP and Head of Programs & Portfolio; led hemoglobinopathy partnership with Vertex.
Annual salary of $460,000, target bonus 45% of base, and eligible for equity plans.
Received one-time grant of 20,000 RSUs vesting over 4 years (25% annually).
Employment agreement provides 6-month notice period; 12-month notice and accelerated vesting after change in control.
Bruno holds MBA from Wharton, AB from Princeton; prior McKinsey biotech practice leader.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Julianne Bruno

Chief Operating Officer

CRSP · CRISPR Therapeutics AG

Effective: 2024-05-23
Filed: May 23, 2024, 7:59 PM ET

On May 23, 2024, CRISPR Therapeutics AG (the “Company”) announced the promotion of Julianne Bruno, currently the Company’s Senior Vice President and Head of Programs & Portfolio, to be the Company’s Chief Operating Officer effective as of May 23, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Julianne Bruno was appointed as Chief Operating Officer at CRISPR Therapeutics AG.

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

On May 23, 2024, CRISPR Therapeutics AG (the “Company”) announced the promotion of Julianne Bruno, currently the Company’s Senior Vice President and Head of Programs & Portfolio, to be the Company’s Chief Operating Officer effective as of May 23, 2024.

View on SEC.gov

CRISPR Therapeutics AG filing history →

Source: SEC EDGAR

accession 0000950123-24-005877

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.